Literature DB >> 24142529

NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysis.

Hong-Yu Zhao1, Yan Gu, Yong-Xiang Yi.   

Abstract

NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism has been reported to influence the risk for esophageal cancer (EC) in many studies; however, the results remain controversial and ambiguous. We therefore carried out a meta-analysis of published case-control studies to investigate the association between NQO1 C609T polymorphism and EC susceptibility. Electronic searches were conducted on links between this variant and EC in several databases. Odds ratios (ORs) and 95% confidence intervals (CIs) for homozygous, dominant model, recessive model and allele were calculated to estimate the strength of associations in fixed and random effect models. Heterogeneity and publication bias were also assessed. A total of 11 case-control studies were identified, including1,619 cases and 2,101 controls. C allele was associated with a decreased susceptibility risk of EC compared with the T allele among Chinese (OR = 0.70; 95% CI = 0.59-0.84). The contrast of homozygotes and the recessive and dominant models produced the same pattern of results as the allele contrast. Our pooled data suggest a significant association exists between NQO1 C609T polymorphism and EC among Chinese.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24142529     DOI: 10.1007/s13277-013-1292-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  24 in total

1.  Random-effects meta-analyses are not always conservative.

Authors:  C Poole; S Greenland
Journal:  Am J Epidemiol       Date:  1999-09-01       Impact factor: 4.897

Review 2.  Esophageal cancer.

Authors:  Peter C Enzinger; Robert J Mayer
Journal:  N Engl J Med       Date:  2003-12-04       Impact factor: 91.245

3.  NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China.

Authors:  Jian-Hui Zhang; Yan Li; Rui Wang; Helen Geddert; Wei Guo; Deng-Gui Wen; Zhi-Feng Chen; Li-Zhen Wei; Gang Kuang; Ming He; Li-Wei Zhang; Ming-Li Wu; Shi-Jie Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

4.  C609T polymorphism of the NAD(P)H:quinone oxidoreductase I gene does not significantly affect susceptibility for esophageal adenocarcinoma.

Authors:  Burkhard H A von Rahden; Hubert J Stein; Rupert Langer; Claus W von Weyhern; Esther Schenk; Carl Döring; J Rüdiger Siewert; Heinz Höfler; Mario Sarbia
Journal:  Int J Cancer       Date:  2005-01-20       Impact factor: 7.396

5.  Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis.

Authors:  Meenakshi Umar; Rohit Upadhyay; Shaleen Kumar; Uday Chand Ghoshal; Balraj Mittal
Journal:  Cancer Epidemiol       Date:  2012-07-06       Impact factor: 2.984

6.  Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case-control study from Iran.

Authors:  H A Marjani; F Biramijamal; N Rakhshani; A Hossein-Nezhad; R Malekzadeh
Journal:  Genet Mol Res       Date:  2010-02-09

7.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

8.  Glutathione S-transferase M1 null genotype contributes to increased risk of esophageal carcinoma in Chinese population.

Authors:  Shan Zhong; Wei Zhao; Chaojing Lu; Bailing Li; Yang Yuan; Danfeng Guo; Zhijie Chang; Binhua Jiao; Lixin Yang
Journal:  Tumour Biol       Date:  2013-04-28

9.  Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.

Authors:  Jianhui Zhang; Wolfgang A Schulz; Yan Li; Rui Wang; Rainer Zotz; Denggui Wen; David Siegel; David Ross; Helmut E Gabbert; Mario Sarbia
Journal:  Carcinogenesis       Date:  2003-05       Impact factor: 4.944

10.  Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

Authors:  R D Traver; D Siegel; H D Beall; R M Phillips; N W Gibson; W A Franklin; D Ross
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  1 in total

1.  Correlation between NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and increased risk of esophageal cancer: evidence from a meta-analysis.

Authors:  Jingfang Diao; Jie Bao; Jianxin Peng; Jiaqiang Mo; Qing Ye; Junming He
Journal:  Ther Adv Med Oncol       Date:  2016-09-18       Impact factor: 8.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.